Inhaled Dornase Alfa for Treatment of ARDS in Patients With SARS-CoV-2
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Dornase alfa (Primary)
- Indications Adult respiratory distress syndrome; COVID 2019 infections; Respiratory insufficiency
- Focus Therapeutic Use
- Acronyms DORNASESARS2
Most Recent Events
- 04 Feb 2021 Status changed from recruiting to completed.
- 02 Jun 2020 Status changed from not yet recruiting to recruiting.
- 28 May 2020 New trial record